Stocks
Exicure, Inc.XCUR
NASDAQHealthcareBiotechnology$1.05
Price as of · delayed, not real-time
A clinical-stage biotechnology company developing nucleic acid-based therapies, including spherical nucleic acid (SNA) constructs, for a range of genetic and inflammatory diseases. Its lead programs target conditions such as Huntington's disease and certain cancers, though the company has faced significant financial and operational challenges. Investors track XCUR for its potential in novel drug delivery platforms and its high-risk, high-reward profile.
52W Range: $0.94-$9.48
Congressional Interest in Exicure, Inc. (XCUR)
No congressional trades have been disclosed for Exicure, Inc. (XCUR) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading XCUR?
No congressional trades found for this stock.